Fisher Asset Management LLC Has $619,000 Holdings in The Cigna Group (NYSE:CI)

Fisher Asset Management LLC grew its stake in The Cigna Group (NYSE:CI) by 67.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,239 shares of the health services provider’s stock after buying an additional 902 shares during the quarter. Fisher Asset Management LLC’s holdings in The Cigna Group were worth $619,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Prospera Private Wealth LLC bought a new stake in shares of The Cigna Group in the third quarter worth $37,000. Collier Financial bought a new stake in shares of The Cigna Group in the fourth quarter worth $32,000. ORG Wealth Partners LLC bought a new stake in shares of The Cigna Group in the fourth quarter worth $34,000. Harbor Capital Advisors Inc. bought a new stake in shares of The Cigna Group in the third quarter worth $45,000. Finally, Compagnie Lombard Odier SCmA bought a new stake in shares of The Cigna Group in the fourth quarter worth $37,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insiders Place Their Bets

In other The Cigna Group news, CEO David Cordani sold 26,527 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the sale, the chief executive officer now directly owns 127,767 shares in the company, valued at $39,367,568.04. This represents a 17.19 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Nicole S. Jones sold 4,904 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total transaction of $1,511,020.48. Following the completion of the sale, the insider now owns 29,421 shares in the company, valued at approximately $9,065,198.52. The trade was a 14.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.60% of the company’s stock.

The Cigna Group Trading Up 1.8 %

CI stock opened at $315.54 on Friday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The company’s 50-day simple moving average is $291.99 and its 200 day simple moving average is $318.03. The Cigna Group has a 52 week low of $262.03 and a 52 week high of $370.83. The company has a market capitalization of $87.77 billion, a PE ratio of 25.78, a price-to-earnings-growth ratio of 0.98 and a beta of 0.54.

The Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter last year, the company earned $6.79 earnings per share. As a group, sell-side analysts anticipate that The Cigna Group will post 29.77 earnings per share for the current year.

The Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th will be paid a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a yield of 1.91%. This is an increase from The Cigna Group’s previous quarterly dividend of $1.40. The ex-dividend date is Wednesday, March 5th. The Cigna Group’s dividend payout ratio is presently 49.35%.

Analyst Ratings Changes

CI has been the topic of a number of research reports. StockNews.com raised shares of The Cigna Group from a “hold” rating to a “buy” rating in a research report on Wednesday, February 19th. Truist Financial cut their price objective on shares of The Cigna Group from $390.00 to $375.00 and set a “buy” rating on the stock in a research report on Tuesday, February 4th. Cantor Fitzgerald cut their price objective on shares of The Cigna Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a research report on Friday, January 31st. Piper Sandler reissued an “overweight” rating and issued a $348.00 price objective (down previously from $394.00) on shares of The Cigna Group in a research report on Monday, February 3rd. Finally, Barclays dropped their price target on shares of The Cigna Group from $420.00 to $339.00 and set an “overweight” rating on the stock in a research report on Friday, January 31st. Two research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, The Cigna Group presently has a consensus rating of “Buy” and a consensus target price of $372.31.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.